Rheumatoid Arthritis Clinical Trials in Chicago

Showing 21-40 of 3,777 trials

Study of MRM-3379 in Male Participants With Fragile X Syndrome (BLOOM)

NCT07209462

This study is a multicenter, double-blind, randomized, placebo-controlled study to assess the safety and tolerability of 3 doses of MRM-3379 in male participants with Fragile X Syndrome ages 16 to 45 (inclusive). In addition, a parallel cohort of participants ages 13 to \<16 will receive open-label MRM-3379. All participants will participate for 12 weeks of treatment. The study is also intended as a proof-of-concept investigation to evaluate whether MRM-3379 can improve FXS symptoms

Fragile X Syndrome

Mirum Pharmaceuticals, Inc.60 participantsStarted Nov 2025

Phoenix, Arizona, United States • Irvine, California, United States • Orange, California, United States +12 more locations

COMPLETEDPhase 22.2 miles

A Study on the Immune Response and Safety of an RSV Vaccine When Given to Adults 18 Years of Age and Above Who Received Lung or Kidney Transplant and Are at an Increased Risk of Respiratory Syncytial Virus Lower Respiratory Tract Disease and Compared to Healthy Adults 50 Years of Age and Above

NCT05921903

The purpose of this study is to evaluate the immunogenicity, safety, and reactogenicity of the RSVPreF3 OA investigational vaccine in an immunocompromised (lung and renal transplant recipients) population and assess whether a second dose of the vaccine increases the immune response.

Respiratory Syncytial Virus Infections

GlaxoSmithKline386 participantsStarted Jul 2023

Phoenix, Arizona, United States • Chicago, Illinois, United States • Lexington, Kentucky, United States +43 more locations

Study of MRM-3379 in Male Participants With Fragile X Syndrome (BLOOM)

A Study on the Immune Response and Safety of an RSV Vaccine When Given to Adults 18 Years of Age and Above Who Received Lung or Kidney Transplant and Are at an Increased Risk of Respiratory Syncytial Virus Lower Respiratory Tract Disease and Compared to Healthy Adults 50 Years of Age and Above

Rheumatoid Arthritis Trials in Other Cities

Early Signals of the Transition From Immune Quiescence to Activation in the Liver Allograft Microenvironment and in the Circulation

A Study to Learn About the Study Medicine Called Rimegepant in Adolescents With Frequent Migraine

A Phase 1 Safety and Dose Finding Study of GLIX1 in Adults With Recurrent or Progressive High-grade Glioma

Evaluation of Treatment Satisfaction and Preference for Sumavel DosePro in the Treatment of Migraine

Cerebral Autoregulation Monitoring During Cardiac Surgery

A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)

Utility of Random Biopsies in Patients With Inflammatory Bowel Disease

Examining the Effects of Intra-detrusor Botox at Time of HoLEP in Men With Overactive Bladder Symptoms

Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma

A Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Subcutaneous Sonelokimab in Participants With Moderate to Severe Hidradenitis Suppurativa

A Study to Assess the Change in Disease Activity in Adult Participants With Moderate to Severe Ulcerative Colitis Treated With Risankizumab Compared to Vedolizumab

A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas

A Study of Mirikizumab (LY3074828) in Pediatric Participants With Moderately to Severely or Active Ulcerative Colitis

A Study to Test Inavolisib Treatment in Participants With Metastatic Castration-Resistant Prostate Cancer

Intrauterine Stent Placement Following Hysteroscopic Septum Resection

Clinical Procedures to Support Research in ALS

Phase 2 Study of ADX-038 in Participants With Geographic Atrophy

Early Detection of Advanced Adenomas and Colorectal Cancer

Other Conditions in Chicago